A hosptial that becomes better at providing patient services could be financially penalized.
If Canada wants to extend drug patents, it should use the opportunity to improve its regulatory system too.
Canadians could have avoided 47 million in-person visits if they had access to consumer health applications.
The implementation of electronic solutions in health care would save patients’ time and improve work efficiencies.
Medicare does not cover the cost of out-of-pocket expenses for most prescription drugs.
Hospital care isn’t structured to treat frail, elderly patients with chronic illnesses.
One 20mg tablet of simvastin, for example, costs 62.5 cents in Ontario, but only 2.4 cents in New Zealand.
Why Canada should care about the Shouldice Hospital deal.